FDA’s Best Practices for Communicating Cybersecurity Vulnerabilities Paper

Read the FDA's Best Practices for Communicating Cybersecurity Vulnerabilities for tips on communicating with patients

If your email program has trouble displaying this email, view as a webpage. FDA Issues Best Practices for Communicating Cybersecurity Vulnerabilities to Patients Today, the U.S. Food and Drug Administration (FDA) issued Best Practices for Communicating Cybersecurity Vulnerabilities to Patients as a resource for industry stakeholders and federal partners to consider when designing a communication approach for patients and caregivers about cybersecurity vulnerabilities. The paper is a result of a recommendation made by the Patient Engagement Advisory Committee (PEAC) during the September 2019 PEAC meeting. The FDA worked with industry stakeholders and federal partners to assess the best approaches to communicate with patients and caregivers about specific and relevant cybersecurity vulnerabilities that may affect them. Best Practices for Communicating Cybersecurity Vulnerabilities to Patients incorporates feedback received from the public on the earlier draft document Communicating Cybersecurity Vulnerabilities to Patients: Considerations for a Framework. This document is not guidance and does not create or convey any policies on regulatory matters or any regulatory expectations. Read the paper Questions? If you have questions about cybersecurity and medical devices, email cybermed@fda.hhs.gov or contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA